ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 245 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $13,582,000 | -70.7% | 336,040 | -58.3% | 0.02% | -64.4% |
| Q2 2015 | $46,360,000 | +121.0% | 805,561 | +144.5% | 0.04% | +114.3% |
| Q1 2015 | $20,979,000 | +7.1% | 329,497 | +3.9% | 0.02% | +23.5% |
| Q4 2014 | $19,587,000 | +62.0% | 317,250 | +1.9% | 0.02% | +70.0% |
| Q3 2014 | $12,088,000 | +51.5% | 311,293 | +34.4% | 0.01% | +42.9% |
| Q2 2014 | $7,977,000 | -18.8% | 231,572 | +1.9% | 0.01% | -30.0% |
| Q1 2014 | $9,820,000 | -29.8% | 227,262 | -35.3% | 0.01% | -23.1% |
| Q4 2013 | $13,993,000 | +36.5% | 351,216 | +28.6% | 0.01% | +30.0% |
| Q3 2013 | $10,250,000 | +52.7% | 273,039 | +9.3% | 0.01% | +42.9% |
| Q2 2013 | $6,713,000 | +29.2% | 249,855 | -18.5% | 0.01% | +40.0% |
| Q1 2013 | $5,194,000 | – | 306,688 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |